An introduction to CNS-resident microglia: Definitions, assays, and functional roles in health and disease

Neural-Immune Interactions in Brain Function and Alcohol Related Disorders

Volumn , Issue , 2013, Pages 3-29

  Davis, Deirdre S ^a   Carson, Monica J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84888125053     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-4729-0_1     Document Type: Chapter

References (128)

1. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science (New York) 308: 1314-1318
2. Colton CA et al (2006) Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 3: 27
3. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969
4. D'Mello C, Le T, Swain MG (2009) Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor alpha signaling during peripheral organ inflammation. J Neurosci 29: 2089-2102
5. Chew LJ, Takanohashi A, Bell M (2006) Microglia and inflammation: impact on developmental brain injuries. Ment Retard Dev Disabil Res Rev 12: 105-112
6. Doorduin J, deVries EFJ, Willemsen ATM, Dierckx RA, Klein HC (2008) Neuroinflammation in schizophrenic patients: a positron emission tomography study with [11C]-(R)-PK11195. Neuroimage 41: T109
7. Pardo CA, Vargas DL, Zimmerman AW (2005) Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry (Abingdon) 17: 485-495
8. Hickie IB, Banati R, Stewart CH, Stewart CH, Lloyd AR (2009) Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders. Med J Aust 190: S17-S21
9. Haynes R et al (2003) Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 62: 441-450
10. Frank M et al (2006) mRNA upregulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol Aging 27: 717-722
11. Dilger RN, Johnson RW (2008) Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J Leukoc Biol 84: 932-939
12. Godbout J et al (2005) Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J 19: 1329-1331
13. Henry C, Huang Y, Wynne A, Godbout J (2009) Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1 b and anti-inflammatory IL-10 cytokines. Brain Behav Immun 23: 309-317
14. Carson MJ, Reilly CR, Sutcliffe JG, Lo D (1998) Mature microglia resemble immature antigen-presenting cells. Glia 22: 72-85
15. Melchior B, Puntambekar SS, Carson MJ (2006) Microglia and the control of autoreactive T cell responses. Neurochem Int 49: 145-153
16. Carson M, Doose J, Melchior B, Schmid C, Ploix C (2006) CNS immune privilege: hiding in plain sight. Immunol Rev 213: 48-65
17. Carson M, Thrash J, Walter B (2006) The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res 6: 237-245
18. Biber K, Neumann H, Inoue K, Boddeke HWGM (2007) Neuronal "on" and "off" signals control microglia. Trends Neurosci 30: 596-602
19. Andjelkovic AV, Nikolic B, Pachter JS, Zecevic N (1998) Macrophages/microglial cells in human central nervous system during development: an immunohistochemical study. Brain Res 814: 13-25
20. Lichanska AM et al (1999) Differentiation of the mononuclear phagocyte system during mouse embryogenesis: the role of transcription factor PU. 1. Blood 94: 127-138
21. Soulet D, Rivest S (2008) Bone-marrow-derived microglia: myth or reality. Curr Opin Pharmacol 8: 508-518
22. Hutchins K, Dickson D, Rashbaum W, Lyman W (1990) Localization of morphologically distinct microglial populations in the developing human fetal brain: implications for ontogeny. Brain Res Dev Brain Res 55: 95-102
23. Schmid CD et al (2002) Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem 83: 1309-1320
24. Ginhoux F et al (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science (New York) 330: 841-845
25. Carson MJ, Crane J, Xie AX, Silva GA (2009) Modeling CNS microglia: the quest to identify predictive models. Drug Discov Today 5: 19-25
26. Ransohoff RM, Cardona AE (2010) The myeloid cells of the central nervous system parenchyma. Nature 468: 253-262
27. Carson M et al (2007) A rose by any other name. The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics 4: 571-579
28. Carson MJ, Thrash JC, Walter B (2009) The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci 6: 237-245
29. Thomas M (1989) The leukocyte common antigen family. Annu Rev Immunol 7: 339-369
30. Tan J, Town T, Mullan M (2000) CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J Biol Chem 275: 37224-37231
31. Sedgwick JD et al (1991) Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci USA 88: 7438-7442
32. Ford AL, Goodsall AL, Hickey WF, Sedgwick JD (1995) Normal adult ramified microglia separated from other central nervous system macrophages byflow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J Immunol 154: 4309-4321
33. Kovács R, Papageorgiou I, Heinemann U (2011) Slice cultures as a model to study neurovascular coupling and blood brain barrier in vitro. Cardiovasc Psychiatry Neurol 2011: 646958
34. Davalos D et al (2008) Stable in vivo imaging of densely populated glia, axons and blood vessels in the mouse spinal cord using two-photon microscopy. J Neurosci Methods 169: 1-7
35. Germain R, Miller M, Dustin M, Nussenzweig M (2006) Dynamic imaging of the immune system: progress, pitfalls and promise. Nat Rev Immunol 6: 497-507
36. Greer J, Capecchi M (2002) Hoxb8 is required for normal grooming behavior in mice. Neuron 33: 23-34
37. Tremblay M, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A (2011) The role of microglia in the healthy brain. J Neurosci 31: 16064-16069
38. Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SBG, Guyenet PG, Kipnis J (2012) Wild type microglia arrest pathology in mouse model of Rett syndrome. Nature 484: 105-109
39. Verloes A et al (1997) Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia. J Med Genet 34: 753-757
40. Thrash JC, Torbett BE, Carson MJ (2009) Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease. Neurochem Res 34: 38-45
41. Paloneva J et al (2000) Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet 25: 357-361
42. Paloneva J et al (2003) DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med 198: 669-675
43. Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H (2007) TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 4: e124. doi: 10. 1371/journal. pmed. 0040124
44. Melchior B et al (2010) Dual induction of TREM2 and tolerance related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease. ASN Neuro 2: e00037. doi: 10. 1042/AN20100010
45. Bouchon A, Facchetti F, Weigand MA, Colonna M (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410: 1103-1107
46. Piccio L et al (2007) Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 37: 1290-1301
47. Hristova M et al (2010) Activation and deactivation of periventricular white matter phagocytes during postnatal mouse development. Glia 58: 11-28
48. Blaschke AJ, Staley K, Chun J (1996) Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. Development 122: 1165-1174
49. Cheng X-S et al (2011) Neuronal apoptosis in the developing cerebellum. Anat Histol Embryol 40: 21-27
50. Ferrer I, Bernet E, Soriano E, del Rio T, Fonseca M (1990) Naturally occurring cell death in the cerebral cortex of the rat and removal of dead cells by transitory phagocytes. Neuroscience 39: 451-458
51. Stein BM, Keshav S, Harris N, Gordon S (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287-292
52. Buchmeier N, Schreiber R (1985) Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci USA 82: 7404-7408
53. Nathan BYCF, Murray HW, Wlebe IE, Rubin BY, Berish Y (1983) Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158: 670-689
54. Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27: 451-483
55. Agarwal S, Piesco N, Johns L, Riccelli A (1995) Differential expression of IL-1 beta, TNFalpha, IL-6, and IL-8 in human monocytes in response to lipopolysaccharides from different microbes. J Dent Res 74: 1057-1065
56. Seder R et al (1991) Mouse splenic and bone marrow cell populations that express highaf finity Fc e receptors and produce interleukin 4 are highly enriched in basophils. Proc Natl Acad Sci USA 88: 2835-2839
57. Moqbel R et al (1995) Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol 155: 4939-4947
58. Yoshimoto T, Bendelac A, Watson C, Hu-Li J, Paul W (1995) Role of NK1. 1+ T cells in a TH2 response and in immunoglobulin E production. Science 270: 1845-1847
59. Demeure C et al (1995) Human naïve CD4 T cells produce interleukin-4 priming and acquire a Th2 phenotype upon repetitive stimulations in neutral conditions. Eur J Immunol 25: 2722-2725
60. Seder R et al (1992) CD8+ T cells can be primed in vitro to produce IL-4. J Immunol 148: 1652-1656
61. Wu G, Morris SJ (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336: 1-17
62. Kreider T, Anthony RM, Urban JF, Gause WC (2007) Alternatively activated macrophages in helminth infections. Curr Opin Immunol 19: 448-453
63. Nair M, Cochrane D, Allen J (2003) Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro. Immunol Lett 85: 173-180
64. Owhashi M, Arita H, Niwa A (1998) Production of eosinophil chemotactic factor by CD8+ T cells in Toxocara canis -infected mice. Parasitol Res 84: 136-138
65. Owhashi M, Arita H, Hayai N (2000) Identification of a novel eosinophil chemotactic cytokine (ECF-L) as a chitinase family protein. J Biol Chem 275: 1279-1286
66. Steppan CM et al (2001) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 98: 502-506
67. Mora A et al (2006) Activation of alveolar macrophages via the alternative pathway in herpesvirus induced lungfibrosis. Am J Respir Cell Mol Biol 35: 466-473
68. Pesce JT et al (2009) Retnla (relmalpha/fizz1) suppresses helminth-induced Th2-type immunity. PLoS Pathog 5: e1000393
69. Chen S-K et al (2010) Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 141: 775-785
70. Akiyama H, McGeer P (1990) Brain microglia constitutively express beta-2 integrins. J Neuroimmunol 30: 81-93
71. Wellik D, Hawkes P, Capecchi M (2002) Hox11 paralogous genes are essential for metanephric kidney induction. Genes Dev 16: 1423-1432
72. Hickey W, Kimura H (1988) Perivascular microglial cells of the CNS are bone marrowderived and present antigen in vivo. Science 239: 290-292
73. McMahon E, Bailey S, Castenada C, Waldner H, Miller S (2005) Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 11: 335-339
74. Sanders V, Jones K (2006) Role of immunity in recovery from a peripheral nerve injury. J Neuroimmune Pharmacol 1: 11-19
75. Serpe C, Coers S, Sanders V, Jones K (2003) CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection. Brain Behav Immun 17: 393-402
76. Byram S et al (2004) CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation. J Neurosci 24: 4333-4339
77. Bsibsi M, Ravid R, Gveri CD, van Noort J (2002) Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61: 1013-1021
78. Crack PJ, Bray PJ (2007) Toll-like receptors in the brain and their potential roles in neuropathology. Immunol Cell Biol 85: 476-480
79. Kimbrell D, Beutler B (2001) The evolution and genetics of innate immunity. Nat Rev Genet 2: 256-267
80. Valanne S, Wang J, Rämet M (2011) The drosophila toll signaling pathway. J Immunol 186: 649-656
81. Bowie A, O'Neill L (2000) The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 67: 508-514
82. Bowman C, Rasley A, Tranguch S, Marriott I (2003) Cultured astrocytes express Toll like receptors for bacterial products. Glia 43: 281-291
83. Kurt-Jones E et al (2004) Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 101: 1315-1320
84. Mishra B, Mishra PT, Teale J (2006) Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J Neuroimmunol 181: 46-56
85. Kielian T, Mayes P, Kielian M (2002) Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll like receptor expression. J Neuroimmunol 130: 86-99
86. Rasley A, Anguita J, Marriott I (2002) Borrelia burgdorferi induces inflammatory mediator production by murine microglia. J Neuroimmunol 130: 22-31
87. Dalpke A et al (2002) Immunostimulatory CpG DNA activates murine microglia. J Immunol 168: 4854-4863
88. Olson JK, Miller SD (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173: 3916-3924
89. Mitchell J, Paul-Clark M, Clarke G, McMaster S, Cartwright N (2007) Critical role of Tolllike receptors and nucleotide oligomerisation domain in the regulation of health and disease. J Endocrinol 193: 323-330
90. Wright GJ et al (2000) Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13: 233-242
91. Masocha W (2009) Systemic lipopolysaccharide (LPS)-induced microglial activation results in different temporal reduction of CD200 and CD200 receptor gene expression in the brain. J Neuroimmunol 214: 78-82
92. Mizuno T, Kawanokuchi J, Numata K, Suzumura A (2003) Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 979: 65-70
93. Zujovic V, Benavides J, Vigé X, Carter C, Taupin V (2000) Fractalkine modulates TNF a secretion and neurotoxicity induced by microglial activation. Glia 29: 305-315
94. Yoshida H et al (2001) Synergistic stimulation, by tumor necrosis factor-alpha and interferongamma, of fractalkine expression in human astrocytes. Neurosci Lett 303: 132-136
95. Bazan J et al (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640-644
96. Cardona AE et al (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9: 917-924
97. Perry VH (2004) The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 18: 407-413
98. Dantzer R (2001) Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 933: 222-234
99. Quan N (2008) Immune to brain signaling: how important are the blood-brain barrier independent pathways. Mol Neurobiol 37: 142-152
100. Konsman J, Kelley K, Dantzer R (1999) Temporal and spatial relationships between lipopolysaccharide-induced expression of fos, interleukin-1 b and inducible nitric oxide synthase in rat brain. Neuroscience 89: 535-548
101. Engblom D et al (2003) Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat Neurosci 6: 1137-1138
102. Ching S et al (2007) Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration. J Neurosci 27: 10476-10486
103. Schiltz JC, Sawchenko PE (2002) Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J Neurosci 22: 5606-5618
104. Andreasson K (2010) Emerging roles of PGE2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat 91: 104-112
105. Steinmetz T et al (1988) Phase I study of 24-hour continuous intravenous infusion of recombinant human tumor necrosis factor. J Biol Response Mod 7: 417-423
106. Triozzi P, Kinney P, Rinehart J (1990) Central nervous system toxicity of biological response modifiers. Ann N Y Acad Sci 594: 347-354
107. Pan W, Kastin A (2002) TNF a transport across the blood-brain barrier is abolished in receptor knockout mice. Exp Neurol 174: 193-200
108. Banks WA, Kastin AJ, Ehrensing CA (1994) Blood-borne interleukin-lla is transported across the endothelial blood-spinal cord barrier of mice. J Physiol 479: 257-264
109. Skinner R, Gibson R, Rothwell N, Pinteaux E, Penny J (2009) Transport of interleukin-1 across cerebromicrovascular endothelial cells. Br J Pharmacol 156: 1115-1123
110. Maier S, Goehler L, Fleshner M, Watkins L (1998) The role of the vagus nerve in cytokine to brain communication. Ann N Y Acad Sci 840: 289-300
111. Pavlo VA, Parrish WR, Rosas-Ballina M, Ochani M, Puerta M, Ochani K, Chavan S, Al-Abed Y, Tracey KJ (2009) Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun 23: 41-45
112. Carson MJ, Lo DD (2007) Perspective is everything: an irreverent discussion of CNSimmune system interactions as viewed from different scientific traditions. Brain Behav Immun 21: 367-373
113. Perry V, Anderson P (1992) The inflammatory response in the CNS. Neuropathol Appl Neurobiol 18: 454-459
114. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57: 67-81
115. Bax M et al (2005) Proposed definition and classification of cerebral palsy. Dev Med Child Neurol 27: 571-576
116. Saadani-Makki F et al (2008) Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. Am J Obstet Gynecol 199: 651. e1-651. e7
117. Wang X, Rousset C, Hagberg H, Mallard C (2006) Lipopolysaccharide-induced inflammation and perinatal brain injury. Semin Fetal Neonatal Med 11: 343-353
118. Dammann O, O'Shea TM (2008) Cytokines and perinatal brain damage. Clin Perinatol 35: 643-663
119. Ashwood P, Van de Water J (2004) A review of autism and the immune response. Clin Dev Immunol 11: 165-174
120. Gupta S, Aggarwal S, Rashanravan B, Lee T (1998) Th1-and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 85: 106-109
121. Kemper T, Bauman M (1998) Neuropathology of infantile autism. J Neuropathol Exp Neurol 57: 645-652
122. Meyer U, Feldon J, Dammann O (2011) Schizophrenia and autism: both shared and disorderspeci fic pathogenesis via perinatal inflammation. Pediatr Res 69: 26R-33R
123. Breier A et al (1992) Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry 49: 921-926
124. Seeman P, Kapur S (2000) Schizophrenia: more dopamine, more D2 receptors. Proc Natl Acad Sci USA 97: 7673-7675
125. O'Donnell M et al (1996) Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. Psychiatry Res 65: 171-178
126. Potvin S et al (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63: 801-808
127. Rantakallio P, Jones P, Moring J, Von Wendt L (1997) Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int J Epidemiol 26: 837-843
128. Mott RT et al (2004) Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia 46: 369-379